Your browser doesn't support javascript.
loading
Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial.
Reardon, David A; Kim, Tae Min; Frenel, Jean-Sebastien; Simonelli, Matteo; Lopez, Juanita; Subramaniam, Deepa S; Siu, Lillian L; Wang, Hui; Krishnan, Suba; Stein, Karen; Massard, Christophe.
Afiliação
  • Reardon DA; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kim TM; Seoul National University Hospital, Seoul, South Korea.
  • Frenel JS; Institut de Cancérologie de l'Ouest, Nantes, France.
  • Simonelli M; Humanitas University, Department of Biomedical Sciences, Milan, Italy.
  • Lopez J; Humanitas Clinical and Research Center-IRCCS, Humanitas Cancer Center, Milan, Italy.
  • Subramaniam DS; Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom.
  • Siu LL; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
  • Wang H; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Krishnan S; MSD China, Beijing, China.
  • Stein K; Merck & Co., Inc., Kenilworth, New Jersey.
  • Massard C; Merck & Co., Inc., Kenilworth, New Jersey.
Cancer ; 127(10): 1620-1629, 2021 05 15.
Article em En | MEDLINE | ID: mdl-33496357
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article